Rina Ariga (@rinaariga) 's Twitter Profile
Rina Ariga

@rinaariga

Medical Director of Global CRO | Cardiologist | Clinician Scientist @UniofOxford | Clinical Trials, Heart Failure, Inherited Cardiac Conditions and Imaging

ID: 1123997013199204352

calendar_today02-05-2019 17:05:45

128 Tweet

215 Followers

390 Following

Muthu Vaduganathan (@mvaduganathan) 's Twitter Profile Photo

Across #SGLT2i evidence, #HF RCTs enrolled some of oldest, frailest, & highest risk pts Yet, consistent ↓ in *all-cause* & HF events w safest profile of any in current HF care In HF, #NNT to prevent CV ☠️ or HF 🏥 25 HF 🏥 28 CV ☠️ 88 All-Cause☠️92 Time to implement. John Mandrola, MD

Across #SGLT2i evidence, #HF RCTs enrolled some of oldest, frailest, & highest risk pts

Yet, consistent ↓ in *all-cause* & HF events w safest profile of any in current HF care

In HF, #NNT to prevent
CV ☠️ or HF 🏥 25
HF 🏥 28
CV ☠️ 88
All-Cause☠️92

Time to implement. <a href="/drjohnm/">John Mandrola, MD</a>
Paz Tayal (@doctor_paz) 's Twitter Profile Photo

Fantastic work from Kathryn McGurk James Ware and the CVGenomics team. Hidden amongst the many gems in this work are updated prevalence estimates for #HCM (1:543) and #DCM (1:220). Even more striking- the enormous 🚺🚹 differences in penetrance 🤔 Cardiomyopathy UK

Benoy Shah MD (@dr_benoy_n_shah) 's Twitter Profile Photo

Eighty years ago today – April 26th 1943 – Philip Alexander Poole-Wilson was born. He became a pioneer in the field of heart failure and one of 🇬🇧's most cherished academic cardiologists With family permission, this 🧵remembers ‘PPW’ and his invaluable contributions to medicine

Eighty years ago today – April 26th 1943 – Philip Alexander Poole-Wilson was born. He became a pioneer in the field of heart failure and one of 🇬🇧's most cherished academic cardiologists

With family permission, this 🧵remembers ‘PPW’ and his invaluable contributions to medicine
Sam Freesun Friedman (@lucidtronix) 's Twitter Profile Photo

Our ECG + MRI cross-modal auto-encoder framework is out! We train a model to encode ECGs and MRIs in the same latent space: nature.com/articles/s4146…

Our ECG + MRI cross-modal auto-encoder framework is out!  We train a model to encode ECGs and MRIs in the same latent space: nature.com/articles/s4146…
Robert Avram (@robertavrammd) 's Twitter Profile Photo

Excited to share with you our latest study on #AI and #CARDIOLOGY published in JAMA Cardiology. We demonstrate that standard left coronary angiogram videos can now be used to provide an automated estimation of LVEF. Ft. Geoff Tison sean abreau UOHI Research Services UCSF Cardiology ICMtl

Prof Derek Connolly (@drderekconnolly) 's Twitter Profile Photo

NICE🇬🇧NICE have decided that the SGLT2 inhibitor Dapagliflozin is going to be recommended in Heart Failure with Preserved or Mildly Reduced Ejection Fraction [based on the Deliver Trial] 50% of HF patients have an EF >40% nejm.org/doi/full/10.10… Primary Care Cardiovascular Society British Society for Heart Failure #theFword

NICE🇬🇧<a href="/NICEComms/">NICE</a> have decided that the SGLT2 inhibitor Dapagliflozin is going to be recommended in Heart Failure with Preserved or Mildly Reduced Ejection Fraction [based on the Deliver Trial]

50% of HF patients have an EF &gt;40%

nejm.org/doi/full/10.10…

<a href="/PCCS_UK/">Primary Care Cardiovascular Society</a> <a href="/BSHeartFailure/">British Society for Heart Failure #theFword</a>
Tom Ribeiro (@tomribeiroecg) 's Twitter Profile Photo

Congrats Rohan Khera Veer Sangha Arash Nargesi and all authors for this amazing achievement: a deep learning–based approach that can use ECG images to screen LV systolic dysfunction, validated in several cohorts. Fantastic! t.ly/sdNCN Yale Cardiology Centro de Telessaúde HC-UFMG

Congrats <a href="/rohan_khera/">Rohan Khera</a> <a href="/Veer_Sangha_/">Veer Sangha</a> <a href="/ArashNargesi/">Arash Nargesi</a> and all authors for this amazing achievement: a deep learning–based approach that can use ECG images to screen LV systolic dysfunction, validated in several cohorts. Fantastic!  t.ly/sdNCN <a href="/YaleCardiology/">Yale Cardiology</a> <a href="/CTSHCUFMG/">Centro de Telessaúde HC-UFMG</a>
Sek Kathiresan MD (@skathire) 's Twitter Profile Photo

Wow, wow, wow! In SELECT trial of patients with obesity (mean BMI 33, n>17,000) & prior atherosclerotic cardiovascular disease (but no diabetes), GLP-1 agonist semaglutide 2.4mg once-weekly reduced risk of CV death, heart attack, or stroke (RRR 20%) novonordisk.com/content/nncorp…

Wow, wow, wow!

In SELECT trial of patients with obesity (mean BMI 33, n&gt;17,000) &amp; prior atherosclerotic cardiovascular disease (but no diabetes),

GLP-1 agonist semaglutide 2.4mg once-weekly

reduced risk of CV death, heart attack, or stroke (RRR 20%)

novonordisk.com/content/nncorp…
Eric Topol (@erictopol) 's Twitter Profile Photo

The ability to do continuous, high-resolution ultrasound imaging of an organ in people on the go through a wearable patch is an important innovation nature.com/articles/s4158… Nature Biotechnology Jon-Emile Kenny

The ability to do continuous, high-resolution ultrasound imaging of an organ in people on the go through a wearable patch is an important innovation
nature.com/articles/s4158… <a href="/NatureBiotech/">Nature Biotechnology</a> <a href="/heart_lung/">Jon-Emile Kenny</a>
Betty Raman (@br_cmr) 's Twitter Profile Photo

Many congrats Zakariye Ashkir for winning the CMR 2024 ECA translational award. This is a really proud primary supervisor moment. Thank you to the British Heart Foundation SCMR and special thanks to Rina Ariga and Liz Tunnicliffe for the original ground work in this space.

Many congrats <a href="/Z_Ashkir/">Zakariye Ashkir</a> for winning the CMR 2024 ECA translational award. This is a really proud primary supervisor moment. Thank you to the <a href="/TheBHF/">British Heart Foundation</a> <a href="/SCMR/">SCMR</a> and special thanks to <a href="/RinaAriga/">Rina Ariga</a> and Liz Tunnicliffe for the original ground work in this space.
Rina Ariga (@rinaariga) 's Twitter Profile Photo

Delighted to be asked during American Heart Month to share my thoughts on the current challenges and future innovations for clinical research and trials in heart failure and inherited cardiovascular disease. medpace.com/wp-content/upl… #Cardiology #CardioTwitter

Delighted to be asked during American Heart Month to share my thoughts on the current challenges and future innovations for clinical research and trials in heart failure and inherited cardiovascular disease.
medpace.com/wp-content/upl…

#Cardiology #CardioTwitter
JACC Journals (@jaccjournals) 's Twitter Profile Photo

#ACC24 #JACC LBCT SimPub: IMPROVE-HCM - targeting myocardial energetics with novel mitotrope drug, #ninerafaxstat, was safe and improved exercise capacity and symptoms in nonobstructive HCM. bit.ly/3U7VxO2 #cvHCM Martin Maron, MD Betty Raman Daniele Massera SharonCresciMD

#ACC24 #JACC LBCT SimPub: IMPROVE-HCM - targeting myocardial energetics with novel mitotrope drug, #ninerafaxstat, was safe and improved exercise capacity and symptoms in nonobstructive HCM. bit.ly/3U7VxO2

#cvHCM <a href="/MartinMaronMD/">Martin Maron, MD</a> <a href="/BR_CMR/">Betty Raman</a> <a href="/danmassera/">Daniele Massera</a> <a href="/SharonCresciMD/">SharonCresciMD</a>
Rina Ariga (@rinaariga) 's Twitter Profile Photo

Super proud of my husband for simplifying the complexities of the brain in "Adventures of the Brain" through comic strips! For kids 8+ but an entertaining, informative read for all!

Rina Ariga (@rinaariga) 's Twitter Profile Photo

Many congratulations to my friend and colleague Betty Raman on securing a prestigious Wellcome Fellowship! Your dedication to advancing cardiac MRI in HCM will undoubtedly make a meaningful impact! #cvHCM #WhyCMR

David Ouyang, MD (@david_ouyang) 's Twitter Profile Photo

Congratulations to the InVision Medical Technology Corporation team! It was 1672 days between when I posted our first video online (x.com/david_ouyang/s…) and now with FDA 510k clearance. In between, we've been refining (100x more data than other algorithms) and testing the algorithm (only AI-LVEF